The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates

Explor Target Antitumor Ther. 2024;5(1):120-134. doi: 10.37349/etat.2024.00209. Epub 2024 Feb 20.

Abstract

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers with high mortality rate. Among its various etiological factors, one of the major risk factors for HCC is a chronic infection of hepatitis B virus (HBV). HBV X protein (HBx) has been identified to play an important role in the HBV-induced HCC pathogenesis since it may interfere with several key regulators of many cellular processes. HBx localization within the cells may be beneficial to HBx multiple functions at different phases of HBV infection and associated hepatocarcinogenesis. HBx as a regulatory protein modulates cellular transcription, molecular signal transduction, cell cycle, apoptosis, autophagy, protein degradation pathways, and host genetic stability via interaction with various factors, including its association with various non-coding RNAs. A better understanding on the regulatory mechanism of HBx on various characteristics of HCC would provide an overall picture of HBV-associated HCC. This article addresses recent data on HBx role in the HBV-associated hepatocarcinogenesis.

Keywords: Hepatitis B virus; hepatitis B virus X protein; hepatocellular carcinoma; signalling pathways.

Publication types

  • Review